|
|
||||||||
Cardiac Imaging |
1 From the Depts of Cardiology (S.E.L., H.W.V., J.W.J., P.S., E.E.v.d.W.), Radiology (S.E.L., P.K., H.J.L., A.d.R.), and Medical Statistics (A.H.Z.), Leiden Univ Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; and the Interuniversity Cardiology Inst of the Netherlands, Utrecht (S.E.L, E.E.v.d.W., A.d.R.). Received Mar 2, 2001; revision requested Apr 11; revision received Jun 8; accepted Jul 5. S.E.L. supported by grant 97.173 from the Netherlands Heart Foundation. Address correspondence to A.d.R. (e-mail: a.de_roos@lumc.nl).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: MR and Doppler flow measurements were performed in a small-diameter flow phantom with physiologic flow conditions and at baseline and during adenosine stress in 27 grafts in 23 patients, who were scheduled for cardiac catheterization. At invasive analysis, the grafts were divided into those with stenosis of less than 50% (nonstenotic) and those with stenosis greater than or equal to 50% (stenotic). In vitro velocity values and velocity values in nonstenotic and stenotic grafts were compared with linear regression analysis, and the in vitro interstudy variability was determined.
RESULTS: Excellent correlations in average peak velocity (r = 0.99, P < .001) and diastolic peak velocity (r = 0.99, P < .001) were demonstrated in vitro between MR and Doppler flow measurements, with less than 5% interstudy variability. MR and Doppler flow measurements revealed good correlations in peak velocity and velocity reserve both in nonstenotic (n = 20) (average peak velocity: r = 0.81, P < .001; diastolic peak velocity: r = 0.83, P < .001; velocity reserve: r = 0.56, P = .010) and stenotic (n = 7) (average peak velocity: r = 0.83, P < .001; diastolic peak velocity: r = 0.78, P = .001; velocity reserve: r = 0.70, P = .078) grafts.
CONCLUSION: Fast MR flow mapping provides noninvasive measures of peak velocity and velocity reserve, which closely correlate with Doppler values both in vitro and in nonstenotic and stenotic grafts.
Index terms: Arteries, grafts and prostheses, 943.1269, 949.1269 Arteries, MR, 544.121416, 544.12144, 943.129412, 943.129416, 943.12944 Arteries, stenosis or obstruction, 943.721, 949.721 Blood, flow dynamics Coronary vessels, flow dynamics, 544.731 Magnetic resonance (MR), vascular studies, 943.12944 Ultrasound (US), Doppler studies, 943.12985
| INTRODUCTION |
|---|
|
|
|---|
The availability of a noninvasive diagnostic tool to identify flow-limiting stenoses in coronary artery bypass grafts or in distal vessels (graft stenosis) would be a major step forward in cardiac care. Magnetic resonance (MR) imaging allows measurements of peak velocities and velocity reserve in grafts, indicating the potential value of this modality. Previous MR angiographic and MR flow mapping studies (15) allowed the differentiation between patent and occluded grafts, but the detection of hemodynamically significant graft stenoses has remained difficult. MR flow mapping with a conventional breath-hold flow sequence proved useful in the identification of severe stenoses in the distal left main and proximal and middle left anterior descending coronary artery, whereby a decreased velocity reserve was demonstrated in greater than 70% luminal stenoses (6). Conventional breath-hold MR flow mapping with low temporal resolution has been validated in coronary arteries with Doppler flow measurements and resulted in systematically lower velocities at MR imaging but similar velocity reserve values (69).
Recently, a fast MR flow mapping sequence with turbo-field echo-planar imaging that allowed flow quantification in grafts within a breath hold of 20 cardiac cycles and high temporal resolution was described (10). This permits the functional evaluation of multiple grafts in patients during a single 6-minute adenosine infusion.
The purpose of the study was to validate fast MR flow mapping with intravascular Doppler flow measurements in vitro and in patients with nonstenotic and stenotic grafts.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
MR flow mapping was performed perpendicular to the glass tube under the 10 flow conditions, and measurements were repeated to determine the interstudy variability. A turbo-field echo-planar imaging MR flow sequence involving multiple excitations within one heart phase interval was applied, and each excitation was followed by echo-planar imaging readout. Owing to the use of multiple short echo-planar imaging readouts, this technique allows fast image acquisition while keeping the echo time low (Fig 2). Two alpha pulses, each of which was followed by three echo-planar imaging readouts, were applied per heart phase interval and resulted in a shot length of six k lines and a temporal resolution of 23 msec. Flow-sensitive and flow-compensated images were acquired in 10 shots and resulted in an imaging duration of 20 heartbeats.
|
In Vitro Doppler Flow Measurements
The flow pump and phantom were subsequently placed in another room, apart from the magnet. The MR blood-mimicking fluid was replaced with ultrasonography blood-mimicking fluid (Shelley Medical Imaging Technology), and the system was cleared of air bubbles. A 7-F sheath was introduced to the flow phantom by means of a puncture through the short compliant tube. Subsequently, a 7-F guiding catheter and 0.014-inch Doppler flow wire (Flo Wire; Cardiometrics, Mountain View, Calif) were advanced into the glass tube, placed at a position similar to that in the MR flow measurement, and adjusted until a stable flow signal was acquired. Doppler flow measurements were carried out twice with the same flow conditions as those used during MR imaging.
Patient Population
Patients with a history of coronary artery bypass graft surgery, who were scheduled to undergo cardiac catheterization for the evaluation of recurrent chest pain, were screened from February to July 1999 for potential inclusion in the study. Patients with chronic obstructive pulmonary disease, sick-sinus syndrome, and/or second- or third-degree atrioventricular block were excluded because of contraindication to adenosine (12,13). Other exclusion criteria were unstable angina, presence of a pacemaker, atrial fibrillation, claustrophobia, and inability to lie flat. Patients were not allowed to have caffeine-containing beverages on the day of MR examination and cardiac catheterization. Inclusion and exclusion criteria were met by 33 patients. In eight patients, no paired MR and Doppler flow data were obtained due to logistic reasons (three patients), intravenous administration of nitrates because of chest pain at the time of Doppler flow mapping (one patient), presence of occluded grafts (two patients), no MR flow mapping during stress (one patient), and inability to perform breath holding (one patient).
In 25 patients, paired MR and Doppler flow data were obtained in 30 grafts. MR imaging was performed before cardiac catheterization (mean, 2.9 days ± 2.6; range, 110 days) in 14 patients, the same day in two patients, and after cardiac catheterization (mean, 14.8 days ± 23.6; range, 276 days) in nine patients. No change in the clinical status of patients was found between MR examination and cardiac catheterization. We recorded the sex, age, number of years after bypass surgery, number and type of grafts, medical history, and types of medication. The protocol was approved by the medical ethics committee of Leiden University Medical Center, and all patients gave informed consent.
MR Flow in Bypass Grafts
All patients were examined while in a supine position after the placement of a respiratory belt to monitor the breath-hold procedure, three ECG leads for cardiac triggering, an ECG patch at the center of the thorax for patient monitoring, and the five-element phased-array cardiac synergy coil. Turbo-field echo-planar imaging MR flow mapping was performed in the proximal part of the graft and perpendicular to the graft segment according to a standardized protocol (10,14). We used a fixed-velocity encoding of 75 cm/sec. The distance from the graft origin to the plane of the MR flow image was measured by one author (S.E.L.). Flow mapping was performed during an end-expiratory breath hold of 20 cardiac cycles. To prevent a Valsalva or Müller maneuver, the patient was instructed to breathe in and out three times and stop breathing after expiration, with the mouth open. After the baseline flow measurement, intravenous adenosine infusion (140-µg/kg/min) was started. When maximal hyperemia was achieved after 2 minutes of infusion, the flow measurement was repeated. The ECG signal and blood pressure at baseline and during adenosine-induced stress were monitored and registered (Millennia 3500; Invivo Research, Orlando, Fla) in all patients. The presence and duration of chest pain, dyspnea, flush, headache, and dizziness during the stress test were registered.
Doppler Flow in Bypass Grafts
Vascular access was obtained by using the femoral approach with the Seldinger technique and a 6- or 7-F guiding catheter. An experienced interventional cardiologist advanced a 0.014-inch Doppler guide wire into the graft and positioned it visually at a level similar to that at MR flow measurement. The position was adjusted until a stable signal was acquired, and the baseline peak velocity was measured over at least three entire cardiac cycles. After a bolus injection of 18-µg adenosine into the graft, the hyperemic peak velocity was recorded. When the peak velocity had returned to baseline, baseline and stress peak velocity measurements were repeated. Peak velocity curves, ECG signal, and blood pressure were displayed and imported into a personal computer. Thereafter, 0.3 mg of nitroglycerine was selectively injected into the graft, and the graft was depicted according to standardized procedures. When visual graft evaluation revealed a diameter of stenosis greater than 20% in the graft or coronary segments beyond the distal anastomosis, subsequent quantitative coronary analysis was performed (Heart Core, Leiden, the Netherlands) to quantify the severity and location of stenosis. On the basis of the most severe stenosis in the graft or coronary segments beyond the distal anastomosis, the grafts were divided into two groups: grafts with luminal stenosis of less than 50% (nonstenotic) and grafts with luminal stenosis greater than or equal to 50% (stenotic).
Data Analysis
Paired modulus and phase MR images were analyzed by using an analytic software package (FLOW; Medis, Leiden, the Netherlands). The quality of the MR flow images was evaluated, and the presence and cause of degraded image quality were registered. A region of interest of 2 x 2 pixels was placed on the phase flow images of either the glass tube or the graft by one author (S.E.L.). They were positioned such that the pixels with the highest velocity over the vessel area were included (8). In each cardiac phase, the mean velocity over the region of interest was determined and defined as the peak velocity over the velocity profile. MR peak velocity (cm/sec) was averaged over the cardiac cycle to determine APV, and the highest peak velocity during diastole was defined as the DPV (cm/sec). Velocity reserve was calculated as the ratio between APV during stress and at baseline. Doppler peak velocity was analyzed off-line by using a computer with a custom-made software program and averaged over three cardiac cycles to calculate APV (cm/sec). Similar to the results of MR data analysis, the highest peak velocity during diastole was the DPV, and the velocity reserve was computed as the ratio of the stress and baseline APV.
Statistical Analysis
In vitro MR and Doppler velocities were compared by means of linear regression analysis and analyzed by means of Bland-Altman analysis (15). Interstudy variability (in percentage) of in vitro MR flow measurements was assessed with linear regression analysis of the two MR measurements and calculated as the absolute difference between the two MR measurements divided by their mean. Similarly, the interstudy variability of in vitro Doppler flow measurements was determined.
Since the distribution of in vivo velocity values was highly skewed, log transformation was performed on APV and DPV values obtained at in vivo MR and Doppler measurements. Data were compared with linear regression analysis results and analyzed by means of Bland-Altman analysis (15). The difference in linear regression between nonstenotic and stenotic grafts was compared by means of covariance analysis. In vivo data are represented as geometric means plus or minus coefficients of variation. Differences between (a) baseline and stress velocity values, (b) MR and Doppler data, and (c) velocity values in nonstenotic and stenotic grafts were tested with a paired or unpaired Student t test. A P value of less than .05 was considered to indicate a statistically significant difference.
| RESULTS |
|---|
|
|
|---|
|
|
In 17 (74%) of 23 patients, transient side effects such as chest pain (12 patients), dyspnea (12 patients), flush (12 patients), headache (eight patients), and dizziness (one patient) during adenosine infusion were reported. Within 2 minutes after adenosine infusion, all side effects disappeared in all patients, and none of the MR examinations had to be interrupted because of symptoms.
A diameter of stenosis greater than or equal to 50% was considered hemodynamically significant (1618). Quantitative coronary analyses revealed 20 nonstenotic and seven stenotic grafts (mean luminal stenosis, 59.1% ± 6.9) (Table 1). In four of seven grafts, the stenosis was localized in the graft, and in three patients, the stenosis was present in the coronary artery segments beyond the distal graft anastomosis, whereas the graft itself revealed no significant stenosis. The typical biphasic flow pattern was demonstrated in grafts by using both fast MR flow mapping and the intravascular Doppler flow wire (Fig 4).
|
|
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Recurrent chest pain after coronary artery bypass graft surgery is a frequently seen problem in clinical practice (19,20). The clinicians interest is in whether there is a flow-limiting stenosis in the graft or its distal vessels that requires coronary angiography and potential intervention. To date, coronary angiography in combination with functional analysis is the technique of choice to identify relevant graft stenosis. This, however, is an invasive diagnostic procedure with inherent risks for the patient (21). Thus, ideally, patients without an ischemic cause of postoperative chest pain should be excluded from invasive analysis. Therefore, noninvasive diagnostic screening tests that allow accurate differentiation between patients with and those without significant stenosis in the graft and/or its distal vessels are needed. The exact location of the stenosis in the epicardial vessel, which consists of the graft and coronary artery segments beyond the distal graft anastomosis, will not influence the management, since further invasive analysis will be indicated when a flow-limiting lesion is suspected.
Fast MR flow mapping may fulfill this clinical requirement, since it is a noninvasive diagnostic tool that allows evaluation of graft function that is similar to that with the intravascular Doppler flow wire. Preliminary clinical data in this study indicate that fast MR flow mapping might be able to aid in distinguishing patients with a relevant stenosis in either the graft or the distal vessels from those with normal graft function by means of a lower stress APV and DPV. However, further studies in which consecutive patients with recurrent chest pain after bypass surgery are examined are needed to determine the diagnostic value of this approach.
Physiology in Coronary Artery Bypass Grafts
Normal baseline values of APV and velocity reserve indicate the presence of a nonstenotic epicardial vessel, including the graft and the coronary arteries in the area supplied by the graft. An epicardial vessel stenosis will increase the resistance to flow, which normally results in dilatation of microcirculation to maintain an adequate baseline flow. Due to a dilated state of the microcirculation at baseline, the capacity to increase flow during stress is reduced, resulting in impaired velocity reserve (2224). When the distal microcirculation cannot dilate normally, as in conditions like myocardial infarction, small vessel disease, or left ventricular hypertrophy, the maximal flow in a normal epicardial vessel is reduced during stress, leading to an impaired velocity reserve (25,26).
In this study, both MR and Doppler measurements indicate that baseline APV, although not significantly, and stress APV were impaired in the seven stenotic grafts, as compared with the APV in the 20 nonstenotic grafts and lead to a similar velocity reserve in all grafts. This can be explained by a condition in which both the microcirculation and the epicardial vessel are affected, resulting in lower flow at baseline and during stress because the microcirculation cannot compensate for the reduction in baseline flow. To substantiate this hypothesis, more stenotic grafts need to be studied.
MR Flow Mapping
Conventional MR flow mapping (27,28) has been validated and compared with invasive measurements of coronary flow (69). In accordance with our results, systematically lower peak velocities but a similar velocity reserve, which is a relative index, were demonstrated at MR imaging (29). Conventional breath-hold MR flow mapping typically includes a low temporal resolution with a large image acquisition window (3,4,69,30). Therefore, conventional MR flow mapping may be more susceptible to motion artifacts (31) than breath-hold fast MR flow mapping, which gives flow information every 23 msec during the cardiac cycle.
The fast MR flow sequence used three echo-planar imaging readouts, as opposed to a single-echo phase-contrast sequence. Errors induced at phase evolution over the three echo acquisitions are mainly a problem when there is flow in the readout direction. However, the main component of the velocity vector in the present study was along the section-selection direction, and first-order phase errors (delays during echo-planar imaging readout) were corrected with an echo-planar reference image.
MR versus Doppler Velocities
The lower velocities that were obtained at MR flow mapping, as compared with those obtained with the intravascular Doppler flow wire in the flow phantom and grafts, can be explained by a methodological difference between the two techniques. The region of interest on MR flow images, which consist of 2 x 2 pixels, is much larger than the sample volume of the Doppler flow wire (8). This implies that lower velocities nearer the vessel boundary are included in the MR flow analysis, leading to an underestimation of peak velocities at MR imaging. Another reason for the underestimation of peak velocities at MR imaging may be that peak velocities are missed during MR data acquisition. Although the temporal resolution of the MR sequence is one of the fastest published to date, Doppler measurements are continuous and able to record velocity information throughout the cardiac cycle. However, the averaging effect of MR flow mapping over the 23 msec will be minimal.
In addition, we observed a trend for a larger difference in peak velocity between fast MR flow mapping and the intravascular Doppler flow wire at higher graft flow, and logarithmic transformation corrected for this heteroscedasticity. This phenomenon was only demonstrated at the in vivo measurements, and this indicates that it is not an intrinsic error in the MR measurement. Moreover, errors caused by low signal-to-noise ratio or a high velocity-encoded gradient would result in a higher difference in peak velocity between MR and Doppler measurements at lower flow. A striking difference between grafts and small-diameter glass tubes is that grafts commonly show diffuse atherosclerosis. Vein graft dimensions undergo a variable degree of change after graft placement due to the development of intimal hyperplasia (32,33).
Luminal irregularities, side branches, and curves in the graft result in increased variation in the velocity profile across the vessel area in the in vivo situation, as compared with the in vitro situation. Velocity profiles across the vein graft have indeed shown a skewed pattern in the proximal part of the graft and near the distal anastomosis; even in the middle part of the graft, velocity profiles were not necessarily parabolic (34). Abnormal velocity profiles may influence both MR and Doppler flow measurements and thus result in a relative error between the two flow methods. At higher flow levels, the difference between fast MR flow mapping and the Doppler flow wire has increased. Variations in velocity profiles and turbulent flow, which is becoming more apparent at higher flow, might have contributed to this observation.
Higher flow levels were mainly obtained during the adenosine-induced stress. Adenosine-induced stress was achieved with an intravenous administration during MR imaging and with intracoronary administration during Doppler measurements. Theoretically, the adenosine administration methods might have affected the results in three manners: (a) a less complete coronary vasodilation with intravenous administration, (b) peripheral vasodilation and subsequent reduced aortic pressure with intravenous administration, and (c) an increase in heart rate following the decrease in aortic pressure with intravenous administration.
First, the expected effect from a less complete coronary vasodilation is a reduction in stress peak velocities and velocity reserve at MR imaging. However, it has been demonstrated that both intracoronary and intravenous adenosine induce maximal hyperemia similar to that of intracoronary papaverine (35). Second, the reduced aortic pressure that results from peripheral vasodilation will also reduce stress peak velocities and velocity reserve at MR imaging. In the present study, however, no change in the mean blood pressure was demonstrated during intravenous and intracoronary adenosine administrations, as compared with those at baseline. Third, an increased heart rate will shorten the diastolic phase and result in reduced stress peak velocities and reduced velocity reserve. Indeed, we showed an increased heart rate during the MR stress test, and no change in the heart rate was found during the Doppler stress test. This might be an explanation for the larger difference in peak velocity between MR and Doppler measurements during stress at the higher flow levels, but it does not account for the lower peak velocities at MR imaging, as compared with Doppler measurements at baseline.
In accordance with others (36,37), we demonstrated that variations in heart rate were not associated with substantial changes in velocity reserve. Moreover, the mean MR blood pressure and the mean Doppler aortic pressure did not change during stress, as compared with those at baseline, but the mean Doppler aortic pressure was lower than the mean MR blood pressure. Since there is a linear relationship between the driving pressure and the coronary flow, we expected lower peak velocities during Doppler measurements than at MR imaging.
Study Limitations
We studied one left internal mammary artery graft and 26 vein grafts. Since arterial grafts have a smaller diameter than vein grafts, MR flow mapping might be less accurate in arterial grafts.
Most vein grafts have a considerably larger vessel diameter, as compared with coronary arteries beyond the graft anastomosis, and the overall graft diameter may change over time after bypass surgery as a result of intimal hyperplasia (33). This makes the selection of the reference diameter for quantitative coronary analysis, and thus the reliable assessment of stenosis severity, complicated. Moreover, a 70% stenosis in the native coronary artery will be more likely to impair flow and reach physiologic significance than the same diameter of stenosis in the graft (33). This limits the use of morphologic measures solely for the selection of graft stenoses that require intervention, which underlines the need for functional measures to determine whether lesion specific therapy is required.
In conclusion, fast MR flow mapping provides noninvasive measures of APV, DPV, and velocity reserve, which closely correlate with Doppler values both in vitro and in nonstenotic and stenotic grafts. Since MR flow mapping can be used to determine graft function, it might be a potential noninvasive screening tool for patients who present with recurrent chest pain after bypass surgery. Further studies in which consecutive patients who present with recurrent chest pain after bypass surgery are examined at both MR imaging and cardiac catheterization are needed to determine the diagnostic accuracy of MR flow mapping for the identification and exclusion of relevant lesions.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Author contributions: Guarantors of integrity of entire study, H.W.V., E.E.v.d.W., A.d.R.; study concepts, H.W.V., J.W.J., E.E.v.d.W., A.d.R.; study design, S.E.L., P.K., H.W.V.; literature research, S.E.L., P.K.; clinical studies, S.E.L., P.S., H.W.V., J.W.J.; experimental studies, S.E.L., P.K., P.S., H.J.L.; data acquisition, S.E.L., P.K., H.W.V., J.W.J., P.S.; data analysis/interpretation, S.E.L., P.K., H.J.L.; statistical analysis, S.E.L., A.H.Z., P.S.; manuscript preparation, S.E.L.; manuscript definition of intellectual content, P.K., H.W.V., J.W.J., E.E.v.d.W, A.d.R.; manuscript editing, S.E.L., P.K., H.J.L.; manuscript revision/review, H.W.V., J.W.J., A.H.Z., P.S., E.E.v.d.W., A.d.R.; manuscript final version approval, all authors.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. P. Salm, J. J. Bax, H. W. Vliegen, S. E. Langerak, P. Dibbets, J. W. Jukema, H. J. Lamb, E. K.J. Pauwels, A. de Roos, and E. E. van der Wall Functional significance of stenoses in coronary artery bypass grafts: Evaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF] |
||||
![]() |
L. P. Salm, S. E. Langerak, H. W. Vliegen, J. W. Jukema, J. J. Bax, A. H. Zwinderman, E. E. van der Wall, A. de Roos, and H. J. Lamb Blood Flow in Coronary Artery Bypass Vein Grafts: Volume versus Velocity at Cardiovascular MR Imaging Radiology, September 1, 2004; 232(3): 915 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Langerak, H. W. Vliegen, J. W. Jukema, A. H. Zwinderman, H. J. Lamb, A. de Roos, and E. E. van der Wall Vein Graft Function Improvement after Percutaneous Intervention: Evaluation with MR Flow Mapping Radiology, September 1, 2003; 228(3): 834 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
C R Peebles Non-invasive coronary imaging: computed tomography or magnetic resonance imaging? Heart, June 1, 2003; 89(6): 591 - 594. [Full Text] [PDF] |
||||
![]() |
S. E. Langerak, H. W. Vliegen, J. W. Jukema, P. Kunz, A. H. Zwinderman, H. J. Lamb, E. E. van der Wall, and A. de Roos Value of Magnetic Resonance Imaging for the Noninvasive Detection of Stenosis in Coronary Artery Bypass Grafts and Recipient Coronary Arteries Circulation, March 25, 2003; 107(11): 1502 - 1508. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||